» Articles » PMID: 21856021

Response of Proinflammatory and Anti-inflammatory Cytokines in Calves with Subclinical Bovine Viral Diarrhea Challenged with Bovine Herpesvirus-1

Overview
Date 2011 Aug 23
PMID 21856021
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this work was to investigate the susceptibility of calves infected with bovine viral diarrhea virus (BVDV) against secondary infections. For this purpose, the profile of cytokines implicated in the immune response of calves experimentally infected with a non-cytopathic strain of BVDV type-1 and challenged with bovine herpesvirus 1.1 (BHV-1.1) was evaluated in comparison with healthy animals challenged only with BHV-1.1. The immune response was measured by serum concentrations of cytokines (IL-1β, TNFα, IFNγ, IL-12, IL-4 and IL-10), acute phase proteins (haptoglobin, serum amyloid A and fibrinogen) and BVDV and BHV-1.1 specific antibodies. BVDV-infected calves displayed a great secretion of TNFα and reduced production of IL-10 following BHV-1 infection, leading to an exacerbation of the inflammatory response and to the development of more intense clinical symptoms and lesions than those observed in healthy animals BHV-1-inoculated. A Th1 immune response, based on IFNγ production and on the absence of significant changes in IL-4 production, was observed in both groups of BHV-1-infected calves. However, whereas the animals inoculated only with BHV-1 presented an IFNγ response from the start of the study and high expression of IL-12, the BVDV-infected calves showed a delay in the IFNγ production and low levels of IL-12. This alteration in the kinetic and magnitude of these cytokines, involved in cytotoxic mechanisms responsible for limiting the spread of secondary pathogens, facilitated the dissemination of BHV-1.1 in BVDV-infected calves.

Citing Articles

Nucleotide sequence variants, gene expression and serum profile of immune and antioxidant markers associated with bacterial diarrhea susceptibility in Barki lambs.

Darwish A, Ebissy E, Hafez A, Ateya A, El-Sayed A BMC Vet Res. 2024; 20(1):462.

PMID: 39394128 PMC: 11468138. DOI: 10.1186/s12917-024-04288-1.


Investigation of the safety and protective efficacy of an attenuated and marker -BoHV-1 combined vaccine in bovines.

Zhang S, Liu G, Zhang Y, Wang C, Xu X, Zhao Y Front Immunol. 2024; 15:1367253.

PMID: 38646533 PMC: 11027501. DOI: 10.3389/fimmu.2024.1367253.


Investigation of the Optimal Immunization Dose and Protective Efficacy of an Attenuated and Marker -Bovine Herpesvirus Type 1 Combined Vaccine in Rabbits.

Zhang S, Liu G, Wu W, Yang L, Shirani I, Guo A Animals (Basel). 2024; 14(5).

PMID: 38473133 PMC: 10930465. DOI: 10.3390/ani14050748.


Immune Responses to Influenza D Virus in Calves Previously Infected with Bovine Viral Diarrhea Virus 2.

Bauermann F, Falkenberg S, Rudd J, Peter C, Merchioratto I, Ritchey J Viruses. 2023; 15(12).

PMID: 38140683 PMC: 10747992. DOI: 10.3390/v15122442.


An updated profile of the bovine acute phase response following an intravenous lipopolysaccharide challenge.

Smock T, Rand Broadway P, Burdick Sanchez N, Carroll J, Theurer M, Hales K J Anim Sci. 2023; 101.

PMID: 37115605 PMC: 10199791. DOI: 10.1093/jas/skad133.